Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Anti-NMDA receptor encephalitis is a severe but treatable autoimmune disease of the CNS. However, the use of immunotherapy and long-term outcomes have yet to be defined for this disease. We describe a case of an 18-year-old male diagnosed with anti-NMDAR encephalitis not associated with tumor, which did not respond to initial treatment with immunoglobulin, followed by corticosteroids, cyclophosphamide and evolved with significant clinical improvement after a prolonged course of plasmapheresis. Although it is not possible to affirm the good outcome was due solely to the prolonged plasmapheresis regimen, recently published data shows that improvement may take weeks or months to occur. This case discloses another therapeutic possibility for patients with refractory disease who fail to respond to recommended first-line and second-line therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619454 | PMC |
| http://dx.doi.org/10.1590/S1980-57642014DN81000014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case Report: Acute polymorphic psychosis and NMDA-R IgG antibodies in serum: a follow-up case study.
Front Immunol
September 2025
Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Introduction: Anti-N-methyl-D-aspartate receptor (NMDA-R) encephalitis is a neuropsychiatric disorder with additional psychiatric features caused by NMDA-R immunoglobulin G (IgG) antibodies in cerebrospinal fluid (CSF). This report presents the follow-up of a patient in whom we assumed mild NMDA-R encephalitis in the first psychotic episode.
Case Study: A patient with a prior episode of an acute polymorphic psychotic syndrome relapsed five and a half years later following a severe COVID-19 infection.
Pediatric N-Methyl-d-Aspartate Receptor Encephalitis is Differentiated From Encephalitis Mimickers by Early Elevated Blood Pressure.
Pediatr Neurol
August 2025
Division of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas; Center for Human Immunobiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas. Elec
Background: Pediatric N-methyl-d-aspartate receptor (NMDAR) encephalitis (pNMDARE) is characterized by severe neuropsychiatric symptoms and prolonged hospitalization and recovery. Early pNMDARE diagnosis is complicated by neuropsychiatric mimickers requiring strong clinical suspicion to escalate to the required lumbar puncture (LP), delaying diagnosis and treatment. Since autonomic dysfunction is a cardinal feature of pNMDARE, we hypothesized that early vital signs serve as a potential noninvasive biomarker to screen for appropriate escalation of pNMDARE evaluation.
View Article and Find Full Text PDFAtypical Anti-NMDAR encephalitis presenting with pharyngeal-cervical-bibrachial weakness: A rare case report.
Neurol Sci
September 2025
Department of Neurology, JIPMER, 605006, Puducherry, India.
Postoperative Anti-NMDAR Encephalitis Following Meningioma Resection: Mechanistic Insights.
J Craniofac Surg
September 2025
Department of Neurosurgery, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong, China.
This case report highlights a rare association between anti-NMDAR encephalitis and meningioma, where the patient developed typical autoimmune encephalitis symptoms shortly after tumor resection. Unlike the well-established link with ovarian teratomas, meningioma-associated cases may involve indirect immune mechanisms, such as molecular mimicry or bystander activation, rather than direct antigen exposure. The findings emphasize the need for postoperative autoimmune screening in neurosurgical patients with unexplained neuropsychiatric symptoms.
View Article and Find Full Text PDFImaging biomarkers in antibody-mediated autoimmune encephalitis.
Quant Imaging Med Surg
September 2025
Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Background: Imaging, particularly multimodal magnetic resonance imaging (MRI), serves as an essential auxiliary examination for diagnosing autoimmune encephalitis (AE). The diversity of autoantibodies complicates the imaging presentation of AE, exhibiting both common and individual features across different subtypes of AE. Currently, there is a lack of comprehensive studies on the imaging features of different subtypes of AE.
View Article and Find Full Text PDF